Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.
New prophylactic and therapeutic strategies to combat human infections with highly pathogenic avian influenza (HPAI) H5N1 viruses are needed. We generated neutralizing anti-H5N1 human monoclonal antibodies (mAbs) and tested their efficacy for prophylaxis and therapy in a murine model of infection.Us...
Main Authors: | Cameron P Simmons, Nadia L Bernasconi, Amorsolo L Suguitan, Kimberly Mills, Jerrold M Ward, Nguyen Van Vinh Chau, Tran Tinh Hien, Federica Sallusto, Do Quang Ha, Jeremy Farrar, Menno D de Jong, Antonio Lanzavecchia, Kanta Subbarao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-05-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC1880850?pdf=render |
Similar Items
-
Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.
by: Surender Khurana, et al.
Published: (2009-04-01) -
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.
by: Amorsolo L Suguitan, et al.
Published: (2006-09-01) -
Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus.
by: Seema S Lakdawala, et al.
Published: (2011-12-01) -
Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus.
by: Philippe Buchy, et al.
Published: (2010-05-01) -
Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue.
by: Vianney Tricou, et al.
Published: (2011-09-01)